Archived Pharmacy Announcements
Notice regarding Omontys Recall
Note: 02/24/2013: FDA is alerting health care providers and patients of a voluntary nationwide recall of ALL lots of Omontys Injection by Affymax and Takeda Pharmaceuticals. The recall is due to reports of anaphylaxis, some fatal. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys and return the product to Takeda. For details, please visit the FDA page and the Takeda/Affymax News Release.
Announcement - 5010 D.O Information
Please be advised that the Department for Medicaid Services and the Magellan Medicaid Administration will be transitioning from NCPDP Version 5.1 to NCPDP Version D.0 in the Kentucky Medicaid Pharmacy Program on Jan. 1, 2012. Updates
Announcement 2009-2010 RSV Season
Sept. 1, 2009
The Department for Medicaid Services has made a change in policy related to the use of Synagis®. The department will closely follow the new recommendations from the American Academy of Pediatrics for the appropriate utilization of Synagis® for the prevention of respiratory syncytial virus (RSV). As a result, the 2009 RSV season will begin Nov. 1, 2009 and continue through March 31, 2010.
Announcement - National Provider Identifier (NPI) - Final Implementation Date
Oct. 8, 2008
This notice serves as a final reminder that submission of the prescriber's NPI on all pharmacy prescription claims is mandated for Kentucky Medicaid patients.
Click on the National Provider Identifier (NPI) - Final Implementation Date for more information.
National Provider Identifier Information
Pharmacy Provider Letter #A-477 - Submitting NPI and Taxonomy Codes to KyHealth Choices (03/20/07)
For more information on submitting your NPI and taxonomy code(s):